FDA USER FEES TO SPEED DRUG REVIEW

被引：0

作者：

DICKINSON, SLJ

机构：

来源：

SCIENTIST | 1992年 / 6卷 / 24期

关键词：

D O I：

暂无

中图分类号：

G25 [图书馆学、图书馆事业]; G35 [情报学、情报工作];

学科分类号：

1205 ; 120501 ;

摘要：

PAYING DUES: A new statute authorizing the Food and Drug Administration to impose "user fees" on drug companies to finance 600 new reviewers is drawing enthusiastic support from many of those same companies, which see the added FDA staffing speeding their products to market; but others are worried that the bill raises conflict-of-interest and undue influence issues.

引用

页码：3 / &

共 50 条

[1] USER FEES PLANNED TO SPEED FDA DRUG REVIEW
HANSON, D
[J]. CHEMICAL & ENGINEERING NEWS, 1992, 70 (33) : 6 - 7
[2] USER FEES TO HASTEN FDA REVIEW
GERSHON, D
[J]. NATURE, 1992, 359 (6396) : 567 - 567
[3] FDA, INDUSTRY AGREE ON DRUG USER FEES
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2011, 89 (37) : 17 - 17
[4] Side effects from FDA's drug user fees
Hileman, B
[J]. CHEMICAL & ENGINEERING NEWS, 2002, 80 (41) : 43 - 43
[5] FDA Announces 2012 Prescription-Drug User Fees
Ritter, Amy
[J]. BIOPHARM INTERNATIONAL, 2011, 24 (09) : 16 - 16
[6] FDA user fees and innovation
Somberg, John C.
[J]. AMERICAN JOURNAL OF THERAPEUTICS, 2008, 15 (02) : 97 - 97
[7] FDA User Fees Reauthorized
Wechsler, Jill
[J]. BIOPHARM INTERNATIONAL, 2022, 35 (11) : 8 - 9
[8] FDA USER FEES SWELL
Erickson, Britt E.
[J]. CHEMICAL & ENGINEERING NEWS, 2012, 90 (09) : 48 - 50
[9] FDA USER FEES GAIN MOMENTUM
PUNZO, C
[J]. BIO-TECHNOLOGY, 1992, 10 (09): : 940 - &
[10] FDA USER FEES CONTINUE TO CLIMB
Erickson, Britt
[J]. CHEMICAL & ENGINEERING NEWS, 2013, 91 (16) : 35 - 35

← 1 2 3 4 5 →